LakeShore Biopharma Co., Ltd s (LSBPW)
CareCloud Inc (CCLDO)
GSK plc (GLAXF)
Acadia Healthcare Company Inc (ACHC)
AstraZeneca Plc (AZNCF)
Dermata Therapeutics Inc. (DRMA)
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
Precigen Inc (PGEN)
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
Coya Therapeutics Inc (COYA)
CoyaTherapeutics - Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders
Lixte Biotechnology Holdings Inc. (LIXTW)
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
Moleculin Biotech Inc. (MBRX)
Avanos Medical Inc (AVNS)
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
Lipocine Inc. (LPCN)
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Eli Lilly and Company (LLY)
Lillys sofetabart mipitecan receives U.S. FDAs Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer